Key Metrics
CiteScore 

2.5
H-Index 

18
SJR 

Q3Urology

SNIP 

1.13
Recommended pre-submission checks
Powered by 

Topics Covered on Current Urology
Current Urology Journal Specifications
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Quarterly |
| Publication Time | 24 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Shandong University |
| Frequency | Quarterly |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 24 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Current Urology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Current Urology
Re: Patients with frailty, BPH and indwelling bladder catheter: What are the 1-year outcomes after Rezūm therapy?
- 27 Oct 2025
- Current Urology
Molecular mechanisms and classification of castration-resistant prostate cancer: Insights into androgen receptor, cancer stem cells, and neuroendocrine features
- 21 Oct 2025
- Current Urology
The role of uropathogenic Escherichia coli biofilms in antibiotic-resistant urinary tract infections: Nanoparticle-based, phage therapy, and quorum-sensing inhibitor approaches
- 2 Oct 2025
- Current Urology
Tackling the progression of benign prostatic hyperplasia/benign prostatic obstruction progression: Deobstructing within the "window of curability" (a hypothesis-generating review).
- 10 Sep 2025
- Current urology
Clinical evaluation of combined programmed cell death protein 1 inhibitor and poly(ADP-ribose) polymerase inhibitor in metastatic castration-resistant prostate cancer patients: Insights from a real-world study.
- 4 Sep 2025
- Current urology
Chimeric antigen receptor-based cell therapy for treating urological tumors.
- 29 Aug 2025
- Current urology
Re: Patients with frailty, BPH and indwelling bladder catheter: What are the 1-year outcomes after Rezūm therapy?
- 27 Oct 2025
- Current Urology
Molecular mechanisms and classification of castration-resistant prostate cancer: Insights into androgen receptor, cancer stem cells, and neuroendocrine features
- 21 Oct 2025
- Current Urology
The role of uropathogenic Escherichia coli biofilms in antibiotic-resistant urinary tract infections: Nanoparticle-based, phage therapy, and quorum-sensing inhibitor approaches
- 2 Oct 2025
- Current Urology
Tackling the progression of benign prostatic hyperplasia/benign prostatic obstruction progression: Deobstructing within the "window of curability" (a hypothesis-generating review).
- 10 Sep 2025
- Current urology
Clinical evaluation of combined programmed cell death protein 1 inhibitor and poly(ADP-ribose) polymerase inhibitor in metastatic castration-resistant prostate cancer patients: Insights from a real-world study.
- 4 Sep 2025
- Current urology
Chimeric antigen receptor-based cell therapy for treating urological tumors.
- 29 Aug 2025
- Current urology